Date Filed | Type | Description |
02/14/2022 |
SC 13G/A
| Sessa Capital , L.P. reports a 2.4% stake in XERIS PHARMACEUTICALS INC |
10/15/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
10/07/2021 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
10/05/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
10/05/2021 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
10/05/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/05/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/05/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/05/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
10/05/2021 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
10/05/2021 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
09/14/2021 |
8-K
| Quarterly results |
09/13/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/30/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/30/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/26/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/06/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
08/05/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
08/05/2021 |
8-K
| Quarterly results |
07/30/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/30/2021 |
8-K
| Quarterly results |
07/29/2021 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
07/28/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
07/28/2021 |
8-K
| Quarterly results |
07/19/2021 |
8-K
| Quarterly results |
07/12/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
06/08/2021 |
8-K
| Quarterly results |
05/24/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
05/24/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
05/24/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
05/24/2021 |
425
| Form 425 - Prospectuses and communications, business combinations: |
05/24/2021 |
8-K
| Quarterly results |
05/13/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
05/13/2021 |
8-K
| Quarterly results |
|